research centers


Search results: Found 3

Listing 1 - 3 of 3
Sort by

Article
Treatment of low serum ferritin in females with alopecia by oral iron.

Authors: Wisam Ali Ameen --- Hassanain H. Al-Charrakh
Journal: Iraq Joural of Hematology المجلة العراقية لامراض الدم ISSN: 20728069/25432702 Year: 2015 Volume: 4 Issue: 1 Pages: 126-136
Publisher: Al-Mustansyriah University الجامعة المستنصرية

Loading...
Loading...
Abstract

Background: Hair loss affects over 25% of women in developed countries. Three hairdisorders, androgenetic alopecia, telogen effluvium and alopecia areata which account formost cases of nonscarring alopecia in women. Iron deficiency has been reported in themajority of women presenting with diffuse hair loss. Iron has important function in oxidationreductionreactions, collagen synthesis, and as a co-factor for enzymes.Objectives: To assess the percentage of the low serum ferritin hair loss females and theirresponse to oral iron replacement therapy.Materials and methods: a prospective cohort study conducted in at Marjan teaching hospitalfrom August 2013 to January 2015. It included 72 female complained from diffuse hair losswere enrolled in this study. Full history was taken from all patients and physical examinationswere done both general examination and local examination of the scalp including pull test.Patients were sent to complete blood examinations, serum ferritin. Patients divided in to threegroups according to their response to treatment. Before the treatment the severity of hair losswas assess by VAS.Results: Fifty two patients met criteria of inclusion. Their serum ferritin levels range between(1.4-14.4) with mean 6.16±3.30 their hemoglobin levels were (8.3-13.4) with mean ±SD11.98±1.22. Group I patients included 27 patients (51.9%), their severity of hair loss beforetreatment was assess by VAS which was 9.18±0.84, after two week of treatment the scorebecome 7.33±1.03, P value is < 0.0001; confidence interval 95% = ( 1.477 to 2.277). in groupII patients which included 12 patients (23%), their severity of hair loss before treatment wasassess by VAS which was 9.33±0.49, after two week of treatment the score become 9.08±0.66,P value is 0.081 considered not significant; confidence interval 95% = (-0.037 to 0.537). Theother thirteen patients (25%) represented the third group. All the patients in this group didn’tshow any response to treatmentConclusion: Measurement of serum ferritin level should be done to all patients with chronictelogen effluvium before starting other anti-hair loss modalities. Iron replacement is a safedrug with a few side effects and indicated to all females with low serum ferritin level.

Keywords

ferritin --- female --- hair loss


Article
Extensive Thrombosis of the Portal Venous System Postsplenectomy for a Patient with Thalassemia Intermedia

Authors: Hassanain H. Al-Charrakh --- Adel S. Al-Aqabi
Journal: Iraq Joural of Hematology المجلة العراقية لامراض الدم ISSN: 20728069/25432702 Year: 2014 Volume: 3 Issue: 2 Pages: 132-139
Publisher: Al-Mustansyriah University الجامعة المستنصرية

Loading...
Loading...
Abstract

Portal vein thrombosis is a life threatening complication after splenectomy especially forthalassemia and myelofibrosis and require a high index of suspicion to establish an earlydiagnosis. Prompt anticoagulation should be initiated once the diagnosis is established toprevent potentially fatal complications such as bowel infarction or later portal hypertension.In this case report, we describe a patient with thalassemia intermedia who undergosplenectomy for massive splenomegaly and developed acute portal vein thrombosis.Anticoagulation started but another CT abdomen done 2 months later showed no change inthrombosis in addition , the patient escaped follow up.

Keywords


Article
Pure red cell aplasia in chronic lymphocytic leukemia: Case report and review of literature

Authors: Liqaa M. Al‑Shareefy --- Hassanain H. Al‑Charrakh
Journal: Iraq Joural of Hematology المجلة العراقية لامراض الدم ISSN: 20728069/25432702 Year: 2016 Volume: 5 Issue: 2 Pages: 187-191
Publisher: Al-Mustansyriah University الجامعة المستنصرية

Loading...
Loading...
Abstract

Despite being immune deficient, chronic lymphocytic leukemia (CLL) patients have an increased incidence ofautoimmune cytopenias secondary to autoantibody formation. These are: warm autoimmune hemolytic anemia;idiopathic thrombocytopenia; pure red cell aplasia (PRCA), and In this case report, we describe a patient withCLL who developed severe anemia requiring frequent red cell transfusion after the third cycle of chemotherapy.Blood film showed no evidence of hemolysis and absolute reticulocytopenia. Bone marrow showed erythroidhypoplasia and residual interstitial infiltrate of CLL. The diagnosis of CLL‑induced PRCA was made, and thepatient showed a prompt and dramatic response to treatment with cyclosporine.

Listing 1 - 3 of 3
Sort by
Narrow your search

Resource type

article (3)


Language

English (3)


Year
From To Submit

2016 (1)

2015 (1)

2014 (1)